Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 11/20 | 0.59 |
| ▸ | CA4 | P22748 | 1/20 | 0.59 |
| ▸ | ATM | Q13315 | 1/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.50 |
| ▸ | USP2 | O75604 | 1/20 | 0.45 |
| ▸ | CA1 | P00915 | 10/20 | 0.44 |
| ▸ | CES2 | O00748 | 2/20 | 0.41 |
| ▸ | CES1 | P23141 | 2/20 | 0.41 |
| ▸ | CA12 | O43570 | 1/20 | 0.41 |
| ▸ | CA6 | P23280 | 1/20 | 0.41 |
| ▸ | CA9 | Q16790 | 1/20 | 0.41 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.40 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Isophthalic Acid SCHEMBL11292198 | 0.94 | CA2 (0.59) | CA2CA4ATMTDP1L3MBTL1 | |
| Isophthalic Acid SCHEMBL106980 | 0.94 | CA2 (0.67) | CA2CA4ATMTDP1L3MBTL1 | |
| Isophthalic Acid SCHEMBL3684094 | 0.94 | CA2 (0.59) | CA2CA4ATMTDP1L3MBTL1 | |
| Isophthalic Acid SCHEMBL25202017 | 0.94 | CA2 (0.59) | CA2CA4ATMTDP1L3MBTL1 | |
| Isophthalic Acid SCHEMBL105996 | 0.94 | CA2 (0.59) | CA2CA4ATMTDP1L3MBTL1 | |
| Isophthalic Acid SCHEMBL23035003 | 0.94 | CA2 (0.59) | CA2CA4ATMTDP1L3MBTL1 | |
| Isophthalic Acid SCHEMBL6264265 | 0.94 | CA2 (0.59) | CA2CA4ATMTDP1L3MBTL1 | |
| Isophthalic Acid SCHEMBL23035004 | 0.94 | CA2 (0.59) | CA2CA4ATMTDP1L3MBTL1 | |
| Isophthalic Acid SCHEMBL161261 | 0.94 | CA2 (0.59) | CA2CA4ATMTDP1L3MBTL1 | |
| Isophthalic Acid SCHEMBL995238 | 0.94 | CA2 (0.59) | CA2CA4ATMTDP1L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119133448-A | Iron isophthalate negative electrode material for lithium battery and preparation method thereof | 成都理工大学 | 2024-12-13 | — | — | CN | claimed |
| CN-114085580-A | Water-based metal baking paint and preparation method thereof | 江苏中瀛涂料有限公司 | 2022-02-25 | — | — | CN | claimed |
| CN-119133448-A | Iron isophthalate negative electrode material for lithium battery and preparation method thereof | 成都理工大学 | 2024-12-13 | — | — | CN | disclosed |
| CN-119133448-A | Iron isophthalate negative electrode material for lithium battery and preparation method thereof | 成都理工大学 | 2024-12-13 | — | — | CN | disclosed |
| CN-119133448-A | Iron isophthalate negative electrode material for lithium battery and preparation method thereof | 成都理工大学 | 2024-12-13 | — | — | CN | disclosed |
| CN-114085580-A | Water-based metal baking paint and preparation method thereof | 江苏中瀛涂料有限公司 | 2022-02-25 | — | — | CN | disclosed |
| CN-112351697-A | Evaporator device with material box | 尤尔实验室有限公司 | 2021-02-09 | — | — | CN | disclosed |
| EP-2015647-A2 | IRON COMPLEX FOR USE IN THE TREATMENT AND/OR PREVENTION OF NUTRITIONAL DISORDERS | UNILEVER N.V. (NL) | 2009-01-21 | — | — | EP | disclosed |
| WO-2006037449-A2 | IRON COMPLEX FOR USE IN THE TREATMENT AND/OR PREVENTION OF NUTRITIONAL DISORDERS | UNILEVER N.V. (NL) | 2006-04-13 | — | — | WO | disclosed |
| US-20060078594-A1 | Iron complex | CONOPCO, INC., D/B/A UNILEVER | 2006-04-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060078594-A1 | Iron complex | SLC40A1, FECH, TFRC | CA2 1969/4885CA4 2594/4885ATM 3584/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.